The association between sleep duration and cardiometabolic risk among children and adolescents in the United States (US): A NHANES study
- PMID: 38738838
- DOI: 10.1111/cch.13273
The association between sleep duration and cardiometabolic risk among children and adolescents in the United States (US): A NHANES study
Abstract
Purpose: This work aims to assess the association of sleep duration with cardiometabolic risk (adiposity, blood pressure, lipids, albuminuria and A1C) and to investigate lifestyle factors (physical activity, light exposure, caffeine consumption and sugar consumption) associated with sleep duration in children.
Methods: A nationally representative sample of 3907 children ages 6-17 years enrolled in NHANES from 2011 to 2014 was included in this cross-sectional study. Sleep duration was defined as the daily average time spent sleeping over 7 days as measured by a physical activity monitor (PAM). Participants without valid sleep data for ≥95% of the study were excluded. Regression models were adjusted for age, sex, race, body mass index (BMI) Z score, physical activity and light exposure.
Results: In adjusted regression models, longer sleep duration was associated with lower systolic blood pressure index (β = -3.63 * 10-5, 95% CI -6.99 * 10-5, -2.78 * 10-6, p = 0.035) and BMI Z score (β = -0.001, 95% CI -0.001, 0.000, p = 0.002). In logistic regression models, longer sleep duration was associated with lower odds of obesity (OR = 0.998, 95% CI 0.997, 0.999, p < 0.001) and overweight status (OR = 0.998, 95% CI 0.997, 0.999, p = 0.004). Greater light exposure (β = 6.64 * 10-5, 95% CI 3.50 * 10-5, 9.69 * 10-5, p < 0.001) and physical activity (β = 0.005, 95% CI 0.004, 0.006, p < 0.001) were associated with longer sleep.
Conclusion: Longer sleep duration was associated with lower blood pressure and adiposity measures in children. Improving sleep quality by increasing physical activity and light exposure in childhood may decrease the lifetime risk of cardiometabolic disease.
Keywords: United States; accelerometer; blood pressure (BP); obesity; paediatric.
© 2024 John Wiley & Sons Ltd.
References
REFERENCES
-
- Abreu, G. A., Barufaldi, L. A., Bloch, K. V., & Szklo, M. (2015). A systematic review on sleep duration and dyslipidemia in adolescents: Understanding inconsistencies. Arquivos Brasileiros de Cardiologia, 105, 418–425. https://doi.org/10.5935/abc.20150121
-
- Agirbasli, M., Tanrikulu, A. M., & Berenson, G. S. (2016). Metabolic syndrome: Bridging the gap from childhood to adulthood. Cardiovascular Therapeutics, 34, 30–36. https://doi.org/10.1111/1755-5922.12165
-
- Araghi, M. H., Thomas, G. N., & Taheri, S. (2012). The potential impact of sleep duration on lipid biomarkers of cardiovascular disease. Clinical Lipidology, 7, 443–453. https://doi.org/10.2217/clp.12.43
-
- Barlow, S. E., & Dietz, W. H. (1998). Obesity evaluation and treatment: Expert committee recommendations. Pediatrics, 102, e29. https://doi.org/10.1542/peds.102.3.e29
-
- Belcher, B. R., Wolff‐Hughes, D. L., Dooley, E. R. I. N. E., Staudenmayer, J., Berrigan, D., Eberhardt, M. S., & Troiano, R. P. (2021). U.S. population‐referenced percentiles for wrist‐worn accelerometer‐derived activity. Medicine and Science in Sports and Exercise, 53, 2455–2464. https://doi.org/10.1249/MSS.0000000000002726
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
